Gabelli Funds’s Zura Bio ZURA Stock Holding History

Gabelli Funds’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-93,730	Closed	-$957K	–	1176
2022 Q4	$957K	Sell	93,730 -14,870	-14%	-$151K	0.01%	810
2022 Q3	$1.09M	Hold	108,600	–	–	0.01%	803
2022 Q2	$1.08M	Hold	108,600	–	–	0.01%	827
2022 Q1	$1.08M	Hold	108,600	–	–	0.01%	866
2021 Q4	$1.07M	Hold	108,600	–	–	0.01%	889
2021 Q3	$1.06M	Buy	+108,600	New	+$1.07M	0.01%	886

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Gabelli Funds's ZURA Position: Q1 2023 in Review

Gabelli Funds sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 93,730 shares — an estimated $957K sold.

Gabelli Funds first reported a position in ZURA in Q3 2021 and held it in 6 quarters. The position peaked at $1.09M in Q3 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Gabelli Funds reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Gabelli Funds sold 93,730 Zura Bio shares in Q1 2023, an estimated $957K.
Gabelli Funds first reported a position in Zura Bio in Q3 2021 and held it in 6 quarters.
Gabelli Funds's Zura Bio position peaked at $1.09M in Q3 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.